Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer

MLA

Shu-Yang Li, et al. “Utility of Atherosclerosis-Associated Serum Antibodies against Colony-Stimulating Factor 2 in Predicting the Onset of Acute Ischemic Stroke and Prognosis of Colorectal Cancer.” Frontiers in Cardiovascular Medicine, vol. 10, Feb. 2023. EBSCOhost, https://doi.org/10.3389/fcvm.2023.1042272.

APA

Shu-Yang Li, Yoichi Yoshida, Masaaki Kubota, Bo-Shi Zhang, Tomoo Matsutani, Masaaki Ito, Satoshi Yajima, Kimihiko Yoshida, Seiichiro Mine, Toshio Machida, Aiko Hayashi, Minoru Takemoto, Koutaro Yokote, Mikiko Ohno, Eiichiro Nishi, Kenichiro Kitamura, Ikuo Kamitsukasa, Hirotaka Takizawa, Mizuki Sata, … Takaki Hiwasa. (2023). Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1042272

Chicago

Shu-Yang Li, Yoichi Yoshida, Masaaki Kubota, Bo-Shi Zhang, Tomoo Matsutani, Masaaki Ito, Satoshi Yajima, et al. 2023. “Utility of Atherosclerosis-Associated Serum Antibodies against Colony-Stimulating Factor 2 in Predicting the Onset of Acute Ischemic Stroke and Prognosis of Colorectal Cancer.” Frontiers in Cardiovascular Medicine 10 (February). doi:10.3389/fcvm.2023.1042272.